 CancerVAX CEO Ryan Davies speaks with Todd Kinard, a leading biotech intellectual property IP expert about how patents can be used to benefit those undertaking early-stage development projects LEHI, Utah, Jan. 20, 2023 GLOBE NEWSWIRE CancerVAX, Inc., a pre-clinical biotechnology company developing immunotherapy cancer treatments that use the bodys immune system to fight cancer, ... The post Ryan Davies Conducts CEO Chat with Leading Biotech IP Expert appeared first on ForexTV... 